Viewing Study NCT06899906


Ignite Creation Date: 2025-12-26 @ 10:58 AM
Ignite Modification Date: 2025-12-31 @ 12:25 AM
Study NCT ID: NCT06899906
Status: RECRUITING
Last Update Posted: 2025-03-28
First Post: 2025-03-21
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Dalbavancin As Suppressive Therapy
Sponsor: Hospices Civils de Lyon
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module